Affiliation:
1. Department of Internal Medicine Yale School of Medicine New Haven Connecticut USA
2. Cancer Outcomes, Public Policy and Effectiveness Research Center Yale School of Medicine New Haven Connecticut USA
3. The Pulmonary Center, Department of Medicine Boston University School of Medicine Boston Massachusetts USA
4. Division of Health Systems Science University of Massachusetts Chan Medical School Worcester Massachusetts USA
5. Institute for Healthcare Delivery & Population Sciences University of Massachusetts Chan Medical School‐Baystate Springfield Massachusetts USA
6. Center for Outcomes Research and Evaluation Yale School of Medicine New Haven Connecticut USA
Abstract
AbstractBackgroundHigh‐intensity end‐of‐life (EOL) care, marked by admission to intensive care units (ICUs) or in‐hospital death, can be costly and burdensome. Recent trends in use of ICUs, life‐sustaining treatments (LSTs), and noninvasive ventilation (NIV) during EOL hospitalizations among older adults with advanced cancer and patterns of in‐hospital death are unknown.MethodsWe used SEER‐Medicare data (2003–2017) to identify beneficiaries with advanced solid cancer (summary stage 7) who died within 3 years of diagnosis. We identified EOL hospitalizations (within 30 days of death), classifying them by increasing intensity of care into: (1) without ICU; (2) with ICU but without LST (invasive mechanical ventilation, tracheostomy, gastrostomy, acute dialysis) or NIV; (3) with ICU and NIV but without LST; and (4) with ICU and LST use. We constructed a multinomial regression model to evaluate trends in risk‐adjusted hospitalization, overall and across hospitalization categories, adjusting for sociodemographics, cancer characteristics, comorbidities, and frailty. We evaluated trends in in‐hospital death across categories.ResultsOf 226,263 Medicare beneficiaries with advanced cancer, 138,305 (61.1%) were hospitalized at EOL [Age, Mean (SD):77.9(7.1) years; 45.5% female]. Overall, EOL hospitalizations remained high throughout, from 78.1% (95% CI: 77.4, 78.7) in 2004 to 75.5% (95% CI: 74.5, 76.2) in 2017. Hospitalizations without ICU use decreased from 49.3% (95% CI: 48.5, 50.2) to 35.0% (95% CI: 34.2, 35.9) while hospitalizations with more intensive care increased, from 23.7% (95% CI: 23.0, 24.4) to 28.7% (95% CI: 27.9, 29.5) for ICU without LST or NIV, 0.8% (95% CI: 0.6, 0.9) to 3.8% (95% CI: 3.4, 4.1) for ICU with NIV but without LST, and 4.3% (95% CI: 4.0, 4.7) to 8.0% (95% CI: 7.5, 8.5) for ICU with LST use. Among those who experienced in‐hospital death, the proportion receiving ICU care increased from 46.5% to 65.0%.ConclusionsAmong older adults with advanced cancer, EOL hospitalization rates remained stable from 2004–2017. However, intensity of care during EOL hospitalizations increased as evidenced by increasing use of ICUs, LSTs, and NIV.
Funder
National Institute on Aging
National Heart, Lung, and Blood Institute
National Institutes of Health
Doris Duke Charitable Foundation
National Comprehensive Cancer Network Foundation
Johnson and Johnson
Reference41 articles.
1. Family Perspectives on End-of-Life Care at the Last Place of Care
2. Perspectives, Preferences, Care Practices, and Outcomes Among Older and Middle-Aged Patients With Late-Stage Cancer
3. Associations Between End-of-Life Discussions, Patient Mental Health, Medical Care Near Death, and Caregiver Bereavement Adjustment
4. Quality ID #455 (NQF 0213): Percentage of Patients Who Died from Cancer Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life (lower score – better) Accessed December 6 2023. Quality ID #455 (NQF 0213): Percentage of Patients Who Died from Cancer Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life (lower score – better).